125 related articles for article (PubMed ID: 38218211)
1. Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.
Liu J; Gu QH; Cui Z; Zhao MH; Jia XY
Clin Immunol; 2024 Feb; 259():109903. PubMed ID: 38218211
[TBL] [Abstract][Full Text] [Related]
2. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
3. A Modified Peptide Derived from Goodpasture Autoantigen Arrested and Attenuated Kidney Injuries in a Rat Model of Anti-GBM Glomerulonephritis.
Shi Y; Jia XY; Gu QH; Wang M; Cui Z; Zhao MH
J Am Soc Nephrol; 2020 Jan; 31(1):40-53. PubMed ID: 31666297
[TBL] [Abstract][Full Text] [Related]
4. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
5. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
6. The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells.
Gu QH; Xu H; Cao X; Cheng X; Jia JY; Yan TK
Int Immunopharmacol; 2024 Mar; 129():111594. PubMed ID: 38295547
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Pusey CD
J Am Soc Nephrol; 2001 Jan; 12(1):61-70. PubMed ID: 11134251
[TBL] [Abstract][Full Text] [Related]
8. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
[TBL] [Abstract][Full Text] [Related]
9. Experimental Antiglomerular Basement Membrane GN Induced by a Peptide from
Gu QH; Huynh M; Shi Y; Jia XY; Luo JJ; Jiang TJ; Cui Z; Ooi JD; Kitching AR; Zhao MH
J Am Soc Nephrol; 2020 Jun; 31(6):1282-1295. PubMed ID: 32444356
[TBL] [Abstract][Full Text] [Related]
10. Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism.
Wu J; Hicks J; Ou C; Singleton D; Borillo J; Lou YH
J Immunol; 2001 Aug; 167(4):2388-95. PubMed ID: 11490029
[TBL] [Abstract][Full Text] [Related]
11. Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat.
Reynolds J; Mavromatidis K; Cashman SJ; Evans DJ; Pusey CD
Nephrol Dial Transplant; 1998 Jan; 13(1):44-52. PubMed ID: 9481714
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD
Kidney Int; 2004 Oct; 66(4):1444-52. PubMed ID: 15458437
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease.
Kuang H; Shen CR; Jia XY; Tan M; Yang XF; Cui Z; Borza DB; Zhao MH
Kidney Int; 2023 Dec; 104(6):1124-1134. PubMed ID: 37598856
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis.
Reynolds J; Norgan VA; Bhambra U; Smith J; Cook HT; Pusey CD
J Am Soc Nephrol; 2002 Feb; 13(2):359-369. PubMed ID: 11805163
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to experimental autoimmune glomerulonephritis in the Wistar Kyoto rat.
Reynolds J; Cook PR; Behmoaras J; Smith J; Bhangal G; Tadros S; Tee J; Salama AD; Evans DJ; Aitman TJ; Cook HT; Pusey CD
Am J Pathol; 2012 May; 180(5):1843-51. PubMed ID: 22445570
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
19. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat.
Reynolds J; Albouainain A; Duda MA; Evans DJ; Pusey CD
Nephrol Dial Transplant; 2006 Dec; 21(12):3398-408. PubMed ID: 16998225
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
